Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial
Authors:
Open Access
- 1 July 2017
- journal article
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 2 (3) , 249-258
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Long-term results of the Dutch randomized prostate cancer trial: Impact of dose-escalation on local, biochemical, clinical failure, and survivalRadiotherapy and Oncology, 2014
- Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate CancerJournal of Clinical Oncology, 2013
- Preliminary Report of a Randomized Dose Escalation Trial for Prostate Cancer using HypofractionationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09Journal of Clinical Oncology, 2010
- Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Hypofractionated Intensity-Modulated Radiotherapy (70 Gy at 2.5 Gy Per Fraction) for Localized Prostate Cancer: Cleveland Clinic ExperienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus ConferenceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 GyJournal of Clinical Oncology, 2006
- Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the ProstateJAMA, 2005
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995